title: Prognostic factors in CLL.
abstract: Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease, as some patients progress rapidly toward the more advanced studies, whereas others survive for a long period without the need for treatment. This heterogeneity of clinical course was somehow unexplained until studies on the CLL cell features disclosed that the CLL clones were heterogeneous and were characterized by different phenotypic and genotypic features in the different patients. On the basis of these observations, it was determined in retrospective studies that clones characterized by unmutated IGHV genes, and/or CD38 and/or ZAP-70 expression conferred a more severe prognosis to the CLL patients. Here, we present data on prospective studies carried out on Binet A-stage patients, in whom the markers were determined at diagnosis and their predictive value was assessed in comparison with chromosomal abnormalities and gene expression or micro RNA profiles. In addition, hypothesis on the potential pathogenetic role of these markers will be presented.
authors.affiliation: IRCCS Azienda Ospedaliera Universitaria San Martino IST , Genova, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Ferrarini
authors.affiliation: IRCCS Azienda Ospedaliera Universitaria San Martino IST , Genova, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Cutrona
authors.affiliation: Dipartimento di Scienze Mediche, Centro di Ricerca per lo Studio delle Leucemie, Università di Milano, U.O. Ematologia 1, Fondazione IRCCS Policlinico , Milano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Neri
authors.affiliation: Unità Operativa Complessa di Ematologia, Azienda Ospedaliera di Cosenza , Cosenza, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Morabito
keywords: Binet A stage; CLL; gene expression profile; miRNA; prognostic markers; score